title: [Risk of central pontine myelinolysis in the treatment of severe hyponatremia].
abstract: Central pontine myelinolysis is a life-threatening condition involving the demyelination of axons in certain areas of the brain. It has been shown almost invariably to occur in connection with hospital care. In recent years, a connection has been noted between the rapid restitution of low serum sodium and the development of the condition. In this review, the most recent scientific information is summarized. It is concluded that the risk should always be considered in treating a hyponatremic patient. The serum sodium level should be raised slowly and the acute treatment ended before normal serum sodium levels are reached, ie when the patient is still slightly hyponatremic.
authors.forename: T
authors.initials: T
authors.lastname: Lindén
authors.forename: H
authors.initials: H
authors.lastname: Haljamäe
authors.forename: C
authors.initials: C
authors.lastname: Nordborg
authors.forename: H
authors.initials: H
authors.lastname: Kalimo
mesh_terms: D003711:Demyelinating Diseases / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007010:Hyponatremia / Q000150:complications* / Q000401:mortality / Q000628:therapy; D009186:Myelin Sheath / Q000473:pathology; D011149:Pons / Q000473:pathology*; D012307:Risk Factors
vernacular_title: Risk för central pontin myelinolys vid korrigering av grav hyponatremi.